Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma

Rewiring local immune milieu by boosting dendritic cell for pancreatic cancer treatment

Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model

Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies

CD133 mRNA-Loaded Dendritic Cell Vaccination Abrogates Glioma Stem Cell Propagation in Humanized Glioblastoma Mouse Model

Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine

Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy

Immunotherapy employing dendritic cell vaccination for patients with advanced or relapsed esophageal cancer

Dendritic cell vaccine as an alternative to opioid analgesia in patients with advanced cervical cancer.

Dendritic Cell-Based Therapy Using LY6E Peptide with a Putative Role Against Colorectal Cancer